Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;9(4):261.
doi: 10.1055/s-0040-1721178. Epub 2021 Jun 15.

Gemcitabine in Recurrent Meningioma

Satvik Khaddar  1 , Arti Bhelekar  1 , Ochin Dale  1 , Litty Varghese  1 , Vijay Maruti Patil  1
Affiliations

Gemcitabine in Recurrent Meningioma

Satvik Khaddar et al. South Asian J Cancer. 2020 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest There are no conflicts of interest.

Figures

None
Dr Vijay M. Patil
See this image and copyright information in PMC

References

    1. Euskirchen P, Peyre M.Management of meningioma Presse Med 201847(11-12 Pt 2)e245–e252. - PubMed
    1. Kaley T, Barani I, Chamberlain M et al.Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review. Neuro-oncol. 2014;16(06):829–840. - PMC - PubMed
    1. Sioka C, Kyritsis A P. Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas. J Neurooncol. 2009;92(01):1–6. - PubMed
    1. Takeda H, Okada M, Kuramoto K et al.Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo. Oncotarget. 2017;8(53):90996–91008. - PMC - PubMed